| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.008 |